Kinesin spindle protein (KSP) inhibitors. Part 2: The design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP
Mark E. Fraley(United States Military Academy), George D. Hartman(United States Military Academy), Edward S. Tasber(United States Military Academy), David Heimbrook(United States Military Academy), Thomayant Prueksaritanont(United States Military Academy), Paul J. Coleman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Robert B. Lobell(United States Military Academy), Nancy E. Kohl(United States Military Academy), Kenneth L. Arrington(United States Military Academy), Cathy Shu(United States Military Academy), Kelly Hamilton(United States Military Academy), Eileen S. Walsh(United States Military Academy), R. M. Garbaccio(Merck & Co., Inc., Rahway, NJ, USA (United States)), Carolyn A. Buser(United States Military Academy), Maricel Torrent(United States Military Academy), Youwei Yan(United States Military Academy), Victoria J. South(United States Military Academy), William F. Hoffman(United States Military Academy), Lawrence C. Kuo(United States Military Academy), Michael D. Schaber(United States Military Academy), Weikang Tao(Jiangsu Hengrui Medicine (China)), Christine Fernandes(United States Military Academy), Hans E. Huber(United States Military Academy)
Cited by 64
Related Papers
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
|Nature|2017|853
The importance of synthetic chemistry in the pharmaceutical industry
|Science|2019|650
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors
|Biochemical Journal|2005|396
CC-1065 and the Duocarmycins: Synthetic Studies
|Chemical Reviews|1997|267